FDA Adverse Event Injury Summary report: N

ONE TOUCH ULTRA

MDR report key: 335715 · Received May 30, 2001

Report

Report Number
2939301-2001-00481
Event Type
Injury
Date Received
May 30, 2001
Date of Event
April 14, 2001
Report Date
May 1, 2001
Manufacturer
LIFESCAN, INC.
Product Code
CFR
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PATIENT

Narratives

Description of Event or Problem · 1

A PATIENT REPORTED EXPERIENCING PAIN IN BOTH FOREARMS 2 WEEKS AFTER USING A ONE TOUCH ULTRASOFT ADJUSTABLE BLOOD SAMPLER FOR ALTERNATE SITE TESTING. ON THE DAY OF THE EVENT, PT WOKE UP WITH PAIN ON BOTH FOREARMS. ABOUT 2 WEEKS LATER, PT SAW PHYSICIAN AFTER PAIN DID NOT SUBSIDE FOR 2 WEEKS. PHYSICIAN TREATED PT WITH THE ANTI-FUNGAL DRUGS, CLOTRIMADERM CREAM AND TERBINAFINE TAB 250MG QD FOR THREE MONTHS FOR AN UNKNOWN DIAGNOSIS. AS OF THE NEXT MONTH, THE TERBINAFINE TAB DOSE HAS BEEN INCREASED TO 375MG QD FOR DIFFICULTY IN BREATHING. PT HAS BEEN USING ACETYL SALICYLIC ACID AS A BLOOD THINNER FOR AN UNKNOWN CONDITION. BLOOD THINNERS COULD LEAD TO ABNORMAL BLEEDING. LATER THAT MONTH, PT WAS STARTED ON THE ANTIBIOTIC RETAMICIN FOR A SYSTEMIC UNKNOWN INFECTION. PT HAS ALSO BEEN EXPERIENCING BILATERAL LOWER LIMB SWELLING OF UNKNOWN CAUSE. FROM THE INFORMATION PROVIDED, THERE IS NO EVIDENCE THAT A DEVICE-RELATED SERIOUS INJURY DID OCCUR. SHOULD NO FURTHER INFORMATION BECOME AVAILABLE, LIFESCAN INC. WILL CONSIDER THE MATTER CLOSED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
24978 ONE TOUCH ULTRA BLOOD GLUCOSE MONITORING KIT/SYSTEM CFR LIFESCAN, INC. NA NA

Patients

Seq Age Sex Outcome Treatment
1 51 YR Required Intervention RETAMICIN.| ACETYL SALICYLIC ACID, TERBINAFINE, CLOTRIMADERM,